fda warning letters bpc 157 2023 2025 to weigh easing limits on unproven peptides favored by RFK Jr. and MAHA supporters Exciting news for peptides coming
Exciting news for peptides coming out of today's committee hearing! The FDA Pharmacy Compounding Advisory Committee voted 8 6 to recommend adding BPC 157 to the 503A Bulks List for use in compounding for Unregulated Peptide Use in the Age of Biohacking: Digital Promotion, Gray Market Access, and Emerging Public Health Risks Cureus 5 GMP Lessons from 2025's FDA Warning Letters FDA Warning Letters Reveal Training Gaps in Life Sciences
Pay in 4 interest-free payments of $5.22 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5


